AI assistant
Sending…
PRECISION BIOSCIENCES INC — Director's Dealing 2023
Sep 5, 2023
34491_dirs_2023-09-05_4179f1a4-1bde-4392-a9b2-6373e9d4499d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2023-08-31
Reporting Person: Kelly John Alexander (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-08-31 | Common Stock | A | 5951 | $0.39 | Acquired | 389291 | Direct |
Footnotes
F1: These shares were acquired under the Issuer's 2019 Employee Stock Purchase Plan subsequent to the Reporting Person's Form 4 filed on August 22, 2023.
More from PRECISION BIOSCIENCES INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8
Regulatory Filings
2026
Mar 17
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19